MA49148A - Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation - Google Patents
Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisationInfo
- Publication number
- MA49148A MA49148A MA049148A MA49148A MA49148A MA 49148 A MA49148 A MA 49148A MA 049148 A MA049148 A MA 049148A MA 49148 A MA49148 A MA 49148A MA 49148 A MA49148 A MA 49148A
- Authority
- MA
- Morocco
- Prior art keywords
- dgla
- acid
- pharmaceutical compositions
- compositions consisting
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762508818P | 2017-05-19 | 2017-05-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA49148A true MA49148A (fr) | 2020-03-25 |
Family
ID=62791771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA049148A MA49148A (fr) | 2017-05-19 | 2018-05-17 | Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20180333382A1 (fr) |
| EP (1) | EP3624787A1 (fr) |
| JP (1) | JP2020520938A (fr) |
| CN (1) | CN110996937A (fr) |
| MA (1) | MA49148A (fr) |
| WO (1) | WO2018211325A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240018593A1 (en) * | 2020-11-30 | 2024-01-18 | Kao Corporation | Method for detecting severity of atopic dermatitis |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006085687A1 (fr) * | 2005-02-14 | 2006-08-17 | Suntory Limited | Préparation contenant de l'acide dihomo-ϝ-linolénique (dgla) au titre de principe actif |
| JP5546087B2 (ja) * | 2005-02-14 | 2014-07-09 | サントリーホールディングス株式会社 | 皮膚疾患経口治療または予防剤 |
| US7485323B2 (en) | 2005-05-31 | 2009-02-03 | Gelita Ag | Process for making a low molecular weight gelatine hydrolysate and gelatine hydrolysate compositions |
| RU2714323C2 (ru) * | 2014-06-04 | 2020-02-14 | ДиЭс БАЙОФАРМА ЛИМИТЕД | Фармацевтические композиции, содержащие дглк, и их применение |
| WO2017118911A1 (fr) * | 2016-01-07 | 2017-07-13 | Dignity Sciences Limited | Compositions pharmaceutiques comprenant de dgla et leur utilisation |
-
2018
- 2018-05-17 US US15/982,599 patent/US20180333382A1/en not_active Abandoned
- 2018-05-17 JP JP2019563872A patent/JP2020520938A/ja active Pending
- 2018-05-17 MA MA049148A patent/MA49148A/fr unknown
- 2018-05-17 EP EP18735690.2A patent/EP3624787A1/fr not_active Withdrawn
- 2018-05-17 WO PCT/IB2018/000623 patent/WO2018211325A1/fr not_active Ceased
- 2018-05-17 CN CN201880047396.1A patent/CN110996937A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020520938A (ja) | 2020-07-16 |
| US20180333382A1 (en) | 2018-11-22 |
| CN110996937A (zh) | 2020-04-10 |
| EP3624787A1 (fr) | 2020-03-25 |
| WO2018211325A1 (fr) | 2018-11-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3630145A4 (fr) | Compositions pharmaceutiques comprenant du cannabidiol et du bêta-caryophyllène et leurs procédés d'utilisation | |
| EP3924481A4 (fr) | Compositions et méthodes de traitement d'hémoglobinopathies | |
| MA52644A (fr) | Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation | |
| MA52257A (fr) | Compositions pharmaceutiques comprenant blautia et leur administration orale | |
| EP3548000A4 (fr) | Compositions pharmaceutiques d'atropine | |
| EP3717636A4 (fr) | Variants de capsides de virus adéno-associé et leurs procédés d'utilisation | |
| EP3715448A4 (fr) | Nouvelles bactéries d'acide lactique et leur utilisation | |
| EP3618871A4 (fr) | Formulations d'anticorps anti-lag3 etco-formulations d'anticorps anti-lag3 et d'anticorps anti-pd-1 | |
| MA43709A (fr) | Composition pharmaceutique comprenant de l'empagliflozine et ses utilisations | |
| MA47688A (fr) | Compositions utiles dans le traitement de l'amyotrophie spinale | |
| EP3880688A4 (fr) | Préparations et compositions d'oligosaccharides | |
| EP3310343A4 (fr) | Compositions implantables pour administration de médicaments et méthodes d'utilisation desdites compositions | |
| EP3380525A4 (fr) | Formulations pharmaceutiques et leurs procédés d'utilisation | |
| EP3518971A4 (fr) | Formulations thérapeutiques d'anticorps et de protéines et leurs utilisations | |
| MA46044A (fr) | Compositions de nettoyage comprenant un acide aminé et leurs procédés d'utilisation | |
| MA48461A (fr) | Excipients pour réduire la viscosité de formulations d'anticorps et compositions de formulation | |
| EP3334719A4 (fr) | Benzimidazoles substitués, préparation et utilisation de ceux-ci en tant qu'agents pharmaceutiques | |
| MA43361A (fr) | Composition pour le soin et la protection de cultures | |
| MA55015A (fr) | Formulations pharmaceutiques | |
| MA41326A (fr) | Formulations pharmaceutiques comprenant du cangrelor de haute pureté et leurs procédés de préparation et d'utilisation | |
| EP3452441A4 (fr) | Dérivés d'acide alpha-truxillique et compositions pharmaceutiques associées | |
| EP3373907A4 (fr) | Compositions pharmaceutiques à libération prolongée et méthodes d'utilisation | |
| EP3664797A4 (fr) | Ligands de nr4a1, compositions pharmaceutiques et procédés d'utilisation associés | |
| EP3402510A4 (fr) | Compositions et formulations comprenant le cabazitaxel et de l'albumine sérique humaine | |
| EP3741376A4 (fr) | Probiotiques pour inhiber et prévenir l'évolution de maladies rénales et compositions pour inhiber et prévenir l'évolution de maladies rénales les comprenant |